Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
483
•Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory•June 18, 2015

Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory – FDA 483, Jun 18, 2015

Record Details

The FDA Form 483 details multiple significant deviations observed during an inspection of a firm's manufacturing and quality control operations.

**Laboratory Control and Data Integrity Issues:** * **Pre-testing and Data Discarding:** The firm's Quality Control laboratory was found to pre-test samples multiple times using electronic chromatography, saving trial data in auxiliary R&D folders. Raw data (e.g., sample weight/dilutions) for these trial analyses were discarded. Historical data for residual solvent by GC testing of API showed potential significant differences between trial and official results, including unknown peaks, which could indicate out-of-specification batches. Lack of supporting raw data prevented accurate calculation of residual solvent levels. * **Non-Contemporaneous Documentation:** QC laboratory records were not documented contemporaneously. Examples include: * A QC analyst pasting balance weighing slips generated on June 11, 2015, onto a worksheet on June 15, 2015, and backdating the signature to June 11, 2015. * An analyst performing a calculation for HPLC analysis on June 15, 2015, based on data from June 10, 2015, with the blank calculation page pre-signed and dated June 10, 2015. * An analyst signing a microbiology testing report on June 17

Company
Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
Inspection date
June 18, 2015
Product type
Cosmetics
Office
Center for Drug Evaluation and Research
Person
  • Peter E. Baker (President)
View Company Profile

ID · 56458423-b281-4593-9ae2-cbdef29b8eb0

Violation Codes6
21 CFR 211FD&C Act 801(a)(3)FD&C Act 501(a)(2)(B)21 CFR 211.6821 CFR 331FD&C Act 704

Full citation text and observation details available on the Dashboard.

Other documents for Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
  • 483 - 2025-03-07March 7, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.